Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 2Recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Sarcoma 111Osteosarcoma 41Sarcoma, Ewing 30Rhabdomyosarcoma 28Melanoma 28Neuroblastoma 21Glioblastoma 18Bone Neoplasms 18Rhabdoid Tumor 17Lymphoma, Non-Hodgkin 17Gliosarcoma 16Neoplasms 15Neoplasm Metastasis 15Liposarcoma 15Breast Neoplasms 15Wilms Tumor 14Ovarian Neoplasms 14Glioma 14Medulloblastoma 13Leiomyosarcoma 13Gastrointestinal Stromal Tumors 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Hepatoblastoma 12Colorectal Neoplasms 12Sarcoma, Synovial 11Ependymoma 11Chordoma 11Carcinoma, Renal Cell 11Neurofibrosarcoma 10

Interventions

CLR1404 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms, Neuroepithelial × Sarcoma × Clear all
NCT03478462 2026-03-18

CLOVER-2

Cellectar Biosciences, Inc.

Phase 1 Active not recruiting
30 enrolled
CNSGenitourinaryLymphoidSarcoma

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Glioma, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Gliosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡